SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3UK'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1WRL_B_TFPB203_1 (TROPONIN C, SLOWSKELETAL AND CARDIACMUSCLES) |
5oe5 | ANTHRANILATE--COALIGASE (Pseudomonasaeruginosa) | 4 / 6 | VAL A 309LEU A 327PHE A 252SER A 223 | 3UK A 900 ( 4.1A)NoneNoneNone | 1.07A | 1wrlB-5oe5A:undetectable | 1wrlB-5oe5A:11.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FK8_A_SAMA302_1 (METHOXY MYCOLIC ACIDSYNTHASE 4) |
5oe5 | ANTHRANILATE--COALIGASE (Pseudomonasaeruginosa) | 3 / 3 | SER A 216THR A 304GLN A 162 | None3UK A 900 (-3.7A)3UK A 900 ( 4.8A) | 0.79A | 2fk8A-5oe5A:undetectable | 2fk8A-5oe5A:21.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NNK_A_ROCA401_3 (PROTEASE) |
4wv3 | ANTHRANILATE-COALIGASE (Stigmatellaaurantiaca) | 5 / 12 | GLY A 337ILE A 314GLY A 316ILE A 317PRO A 342 | NoneNone3UK A 601 (-4.0A)3UK A 601 (-4.0A)None | 0.91A | 2nnkB-4wv3A:undetectable | 2nnkB-4wv3A:10.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QWX_B_ML1B233_1 (RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE[QUINONE]) |
5oe5 | ANTHRANILATE--COALIGASE (Pseudomonasaeruginosa) | 4 / 7 | GLY A 210GLY A 300PHE A 188PHE A 219 | 3UK A 900 ( 3.2A)3UK A 900 (-3.8A)NoneNone | 0.87A | 2qwxA-5oe5A:2.12qwxB-5oe5A:2.2 | 2qwxA-5oe5A:19.952qwxB-5oe5A:19.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2V7B_A_BEZA1529_0 (BENZOATE-COENZYME ALIGASE) |
4wv3 | ANTHRANILATE-COALIGASE (Stigmatellaaurantiaca) | 6 / 9 | PHE A 220ALA A 293GLY A 318HIS A 324ILE A 325LYS A 506 | 3UK A 601 (-4.3A)3UK A 601 (-3.5A)3UK A 601 (-3.5A)3UK A 601 (-3.6A)None3UK A 601 (-2.5A) | 0.53A | 2v7bA-4wv3A:59.8 | 2v7bA-4wv3A:40.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2V7B_A_BEZA1529_0 (BENZOATE-COENZYME ALIGASE) |
5oe5 | ANTHRANILATE--COALIGASE (Pseudomonasaeruginosa) | 6 / 9 | PHE A 209TYR A 211ALA A 278GLY A 279GLY A 302HIS A 308 | 3UK A 900 (-4.2A)3UK A 900 (-4.0A)3UK A 900 ( 2.9A)3UK A 900 (-3.2A)3UK A 900 (-3.4A)3UK A 900 ( 2.8A) | 0.30A | 2v7bA-5oe5A:50.9 | 2v7bA-5oe5A:30.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2V7B_B_BEZB1529_0 (BENZOATE-COENZYME ALIGASE) |
4wv3 | ANTHRANILATE-COALIGASE (Stigmatellaaurantiaca) | 6 / 9 | PHE A 220ALA A 293GLY A 318HIS A 324ILE A 325LYS A 506 | 3UK A 601 (-4.3A)3UK A 601 (-3.5A)3UK A 601 (-3.5A)3UK A 601 (-3.6A)None3UK A 601 (-2.5A) | 0.53A | 2v7bB-4wv3A:59.9 | 2v7bB-4wv3A:40.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2V7B_B_BEZB1529_0 (BENZOATE-COENZYME ALIGASE) |
5oe5 | ANTHRANILATE--COALIGASE (Pseudomonasaeruginosa) | 6 / 9 | PHE A 209TYR A 211ALA A 278GLY A 279GLY A 302HIS A 308 | 3UK A 900 (-4.2A)3UK A 900 (-4.0A)3UK A 900 ( 2.9A)3UK A 900 (-3.2A)3UK A 900 (-3.4A)3UK A 900 ( 2.8A) | 0.28A | 2v7bB-5oe5A:51.0 | 2v7bB-5oe5A:30.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AXT_A_SAMA397_0 (PROBABLEN(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASETRM1) |
5oe5 | ANTHRANILATE--COALIGASE (Pseudomonasaeruginosa) | 5 / 12 | ARG A 393ASP A 299SER A 277GLU A 296ALA A 318 | None3UK A 900 (-2.6A)NoneNoneNone | 1.15A | 3axtA-5oe5A:undetectable | 3axtA-5oe5A:21.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K13_A_THHA642_0 (5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINEMETHYLTRANSFERASE) |
5oe5 | ANTHRANILATE--COALIGASE (Pseudomonasaeruginosa) | 5 / 12 | ASP A 382VAL A 353GLY A 302PHE A 209ILE A 301 | 3UK A 900 (-2.0A)None3UK A 900 (-3.4A)3UK A 900 (-4.2A)3UK A 900 (-4.0A) | 1.14A | 3k13A-5oe5A:undetectable | 3k13A-5oe5A:22.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SNF_A_ACTA110_0 (PROTEIN P-30) |
4wv3 | ANTHRANILATE-COALIGASE (Stigmatellaaurantiaca) | 4 / 5 | ILE A 229THR A 224THR A 221PHE A 77 | NoneNone3UK A 601 (-3.8A)None | 1.17A | 3snfA-4wv3A:undetectable | 3snfA-4wv3A:12.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VNS_A_DVAA602_0 (NRPS ADENYLATIONPROTEIN CYTC1) |
4wv3 | ANTHRANILATE-COALIGASE (Stigmatellaaurantiaca) | 4 / 7 | PHE A 220PHE A 222THR A 320LYS A 506 | 3UK A 601 (-4.3A)3UK A 601 (-4.4A)3UK A 601 (-3.6A)3UK A 601 (-2.5A) | 0.72A | 3vnsA-4wv3A:45.1 | 3vnsA-4wv3A:26.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EAT_A_BEZA1000_0 (BENZOATE-COENZYME ALIGASE) |
4wv3 | ANTHRANILATE-COALIGASE (Stigmatellaaurantiaca) | 4 / 7 | ALA A 293ILE A 317GLY A 318ILE A 325 | 3UK A 601 (-3.5A)3UK A 601 (-4.0A)3UK A 601 (-3.5A)None | 0.33A | 4eatA-4wv3A:57.4 | 4eatA-4wv3A:42.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EAT_A_BEZA1000_0 (BENZOATE-COENZYME ALIGASE) |
5oe5 | ANTHRANILATE--COALIGASE (Pseudomonasaeruginosa) | 5 / 7 | TYR A 211ALA A 278GLY A 279ILE A 301GLY A 302 | 3UK A 900 (-4.0A)3UK A 900 ( 2.9A)3UK A 900 (-3.2A)3UK A 900 (-4.0A)3UK A 900 (-3.4A) | 0.38A | 4eatA-5oe5A:49.3 | 4eatA-5oe5A:28.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EAT_B_BEZB1000_0 (BENZOATE-COENZYME ALIGASE) |
4wv3 | ANTHRANILATE-COALIGASE (Stigmatellaaurantiaca) | 5 / 9 | ALA A 293ILE A 317GLY A 318HIS A 324ILE A 325 | 3UK A 601 (-3.5A)3UK A 601 (-4.0A)3UK A 601 (-3.5A)3UK A 601 (-3.6A)None | 0.30A | 4eatB-4wv3A:57.5 | 4eatB-4wv3A:42.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EAT_B_BEZB1000_0 (BENZOATE-COENZYME ALIGASE) |
5oe5 | ANTHRANILATE--COALIGASE (Pseudomonasaeruginosa) | 6 / 9 | TYR A 211ALA A 278GLY A 279ILE A 301GLY A 302HIS A 308 | 3UK A 900 (-4.0A)3UK A 900 ( 2.9A)3UK A 900 (-3.2A)3UK A 900 (-4.0A)3UK A 900 (-3.4A)3UK A 900 ( 2.8A) | 0.34A | 4eatB-5oe5A:49.4 | 4eatB-5oe5A:28.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XNX_A_41XA707_1 (TRANSPORTER) |
5oe5 | ANTHRANILATE--COALIGASE (Pseudomonasaeruginosa) | 5 / 11 | PHE A 188ALA A 278TYR A 258VAL A 309GLY A 300 | None3UK A 900 ( 2.9A)None3UK A 900 ( 4.1A)3UK A 900 (-3.8A) | 1.24A | 4xnxA-5oe5A:undetectable | 4xnxA-5oe5A:21.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YMG_A_SAMA1001_0 (PUTATIVESAM-DEPENDENTO-METHYLTRANFERASE) |
5oe5 | ANTHRANILATE--COALIGASE (Pseudomonasaeruginosa) | 5 / 12 | GLY A 302TYR A 211SER A 280ALA A 303TYR A 378 | 3UK A 900 (-3.4A)3UK A 900 (-4.0A)PEG A 901 (-3.8A)3UK A 900 (-3.4A)None | 1.36A | 4ymgA-5oe5A:undetectable | 4ymgA-5oe5A:21.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L5Z_H_BO2H301_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-3) |
5oe5 | ANTHRANILATE--COALIGASE (Pseudomonasaeruginosa) | 5 / 12 | CYH A 332ALA A 312GLY A 300THR A 323ASP A 382 | NoneNone3UK A 900 (-3.8A)3UK A 900 ( 4.5A)3UK A 900 (-2.0A) | 1.37A | 5l5zH-5oe5A:undetectable5l5zI-5oe5A:undetectable | 5l5zH-5oe5A:19.515l5zI-5oe5A:19.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L5Z_V_BO2V301_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-3) |
5oe5 | ANTHRANILATE--COALIGASE (Pseudomonasaeruginosa) | 5 / 12 | CYH A 332ALA A 312GLY A 300THR A 323ASP A 382 | NoneNone3UK A 900 (-3.8A)3UK A 900 ( 4.5A)3UK A 900 (-2.0A) | 1.38A | 5l5zV-5oe5A:undetectable5l5zW-5oe5A:undetectable | 5l5zV-5oe5A:19.515l5zW-5oe5A:19.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N9X_A_THRA601_0 (ADENYLATION DOMAIN) |
4wv3 | ANTHRANILATE-COALIGASE (Stigmatellaaurantiaca) | 5 / 7 | PHE A 220PHE A 222GLY A 318HIS A 324LYS A 506 | 3UK A 601 (-4.3A)3UK A 601 (-4.4A)3UK A 601 (-3.5A)3UK A 601 (-3.6A)3UK A 601 (-2.5A) | 0.97A | 5n9xA-4wv3A:45.1 | 5n9xA-4wv3A:26.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N9X_A_THRA601_0 (ADENYLATION DOMAIN) |
5oe5 | ANTHRANILATE--COALIGASE (Pseudomonasaeruginosa) | 4 / 7 | PHE A 209GLY A 279GLY A 302HIS A 308 | 3UK A 900 (-4.2A)3UK A 900 (-3.2A)3UK A 900 (-3.4A)3UK A 900 ( 2.8A) | 1.03A | 5n9xA-5oe5A:40.9 | 5n9xA-5oe5A:29.08 |